Full Press Release Details
Announcement Summary
ALTERITY THERAPEUTICS LIMITED
Date of this announcement
The Proposed issue is:
A placement or other type of issue
Total number of +securities proposed
to be issued for a placement or other type of issue
| ASX +security code | +Security description | Maximum number of +securities to be issued | ||||
| ATH | ORDINARY FULLY PAID | 1,666,666,663 |
Proposed +issue date
Refer to next page for full details of the announcement
Part 1 - Entity and announcement details
ALTERITY THERAPEUTICS LIMITED
We (the entity named above) give ASX the following
information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred
settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.
If the +securities are being offered under a +disclosure
document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under
the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final
number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete
and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation).
| 1.2 Registered number type | Registration number | ||
| ACN | 080699065 |
1.4 The announcement is
1.5 Date of this announcement
1.6 The Proposed issue is:
A placement or other type of issue
Part 7 - Details of proposed placement or other issue
Part 7A - Conditions
7A.1 Do any external approvals need to be obtained
or other conditions satisfied before the placement or other type of issue can proceed on an unconditional basis?
Part 7B - Issue details
| Is the proposed security a New class' (+securities in a class that is not yet quoted or recorded by ASX) or an Existing class' (additional securities in a class that is already quoted or recorded by ASX)? | Will the proposed issue of this +security include an offer of attaching +securities? | ||
| Existing class | No |
Details of +securities proposed to be issued
ASX +security code and description
ATH : ORDINARY FULLY PAID
Number of +securities proposed to be issued
Are the +securities proposed to be issued being
issued for a cash consideration?
| In what currency is the cash consideration being paid? | What is the issue price per +security? | ||
| AUD - Australian Dollar | AUD 0.01200 |
Will these +securities rank equally in all respects
from their issue date with the existing issued +securities in that class?
7C.1 Proposed +issue date
Part 7D - Listing Rule requirements
7D.1 Has the entity obtained, or is it obtaining, +security
holder approval for the entire issue under listing rule 7.1?
7D.1b Are any of the +securities proposed to be issued
without +security holder approval using the entity's 15% placement capacity under listing rule 7.1?
7D.1b ( i ) How many +securities are proposed to be issued without
security holder approval using the entity's 15% placement capacity under listing rule 7.1?
7D.1c Are any of the +securities proposed to
be issued without +security holder approval using the entity's additional 10% placement capacity under listing rule 7.1A (if applicable)?
7D.1c ( i ) How many +securities are proposed to be issued without
+security holder approval using the entity's additional 10% placement capacity under listing rule 7.1A?
7D.1c ( ii ) Please explain why the entity has
chosen to do a placement rather than a +pro rata issue or an offer under a +security purchase plan in which existing ordinary +security
holders would have been eligible to participate
7D.2 Is a party referred to in listing rule 10.11 participating
in the proposed issue?
7D.3 Will any of the +securities to be issued be +restricted
securities for the purposes of the listing rules?
7D.4 Will any of the +securities to be issued be subject
to +voluntary escrow?
Part 7E - Fees and expenses
7E.1 Will there be a lead manager or broker to the
7E.1a Who is the lead manager/broker?
7E.1b What fee, commission or other consideration is
payable to them for acting as lead manager/broker?
7E.2 Is the proposed issue to be underwritten?
7E.4 Details of any other material fees or costs to be incurred
by the entity in connection with the proposed issue
Part 7F - Further Information
7F.01 The purpose(s) for which the entity is issuing the securities
7F.1 Will the entity be changing its dividend/distribution
policy if the proposed issue proceeds?
7F.2 Any other information the entity wishes to provide about the
7F.3 Any on-sale of the +securities proposed
to be issued within 12 months of their date of issue will comply with the secondary sale provisions in sections 707(3) and 1012C(6) of
the Corporations Act by virtue of:
The publication of a cleansing notice under section 708A(5),
708AA(2)(f), 1012DA(5) or 1012DAA(2)(f)